Avastin bevacizumab approval revoked to treat breast cancer in US
Avastin Loses FDA Approval to Treat Breast Cancer – US health agency FDA Commissioner Margaret A. Hamburg, M.D. has revoked the approval of the breast cancer indication for Avastin (bevacizumab) after concluding that the drug has not been shown to be safe and effective for that use.